NISA INVESTMENT ADVISORS, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$61,391
+214.6%
2,001
+310.9%
0.00%
Q2 2023$19,514
+51252.6%
487
-48.0%
0.00%
Q1 2023$38
-37.7%
936
-41.2%
0.00%
Q4 2022$61
-99.9%
1,591
+0.6%
0.00%
-100.0%
Q3 2022$82,000
-18.0%
1,582
-7.5%
0.00%0.0%
Q2 2022$100,000
-17.4%
1,711
+7.8%
0.00%0.0%
Q1 2022$121,000
+12.0%
1,587
-8.0%
0.00%0.0%
Q4 2021$108,000
-65.4%
1,725
-69.0%
0.00%
-50.0%
Q3 2021$312,000
+13.5%
5,571
+22.8%
0.00%0.0%
Q2 2021$275,000
-33.9%
4,538
-23.6%
0.00%
-33.3%
Q1 2021$416,000
+17.2%
5,9380.0%0.00%
+50.0%
Q4 2020$355,000
+171.0%
5,938
+173.0%
0.00%
+100.0%
Q3 2020$131,000
-89.3%
2,175
-90.7%
0.00%
-90.9%
Q2 2020$1,224,000
+369.0%
23,321
+199.4%
0.01%
+266.7%
Q1 2020$261,000
-23.0%
7,790
+4.0%
0.00%0.0%
Q4 2019$339,000
+23.7%
7,490
+4.2%
0.00%
+50.0%
Q3 2019$274,000
-18.7%
7,190
-7.2%
0.00%
-33.3%
Q2 2019$337,000
+14.2%
7,7480.0%0.00%0.0%
Q1 2019$295,000
+1866.7%
7,748
+2113.7%
0.00%
Q4 2018$15,000
-25.0%
350
-13.6%
0.00%
Q3 2018$20,000
+53.8%
4050.0%0.00%
Q2 2018$13,000
+160.0%
405
+131.4%
0.00%
Q1 2018$5,000
-64.3%
175
-56.2%
0.00%
Q3 2016$14,000
+7.7%
4000.0%0.00%
Q2 2016$13,000
-38.1%
4000.0%0.00%
Q1 2016$21,0004000.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders